HLA-DRB5 and autoimmune thrombocytopenic purpura: Therefore, it is indicated that HLA-DRB5 is a potential diagnostic biomarker for ITP, and targeting HLA-DRB5 might be a promising therapeutic strategy to delay the progression of ITP.